Pilot Study Indicates Qualia Mind Improving Reasoning, Episodic Memory, Verbal Ability and Concentration
Neurohacker Collective recently began a pilot study using the CBS Health platform powered by Cambridge Brain Sciences (CBS) — a leading provider of cognitive testing tools—to help customers receive quantitative feedback on their current brain health. In the initial pilot study, customers were self-selected and offered free cognitive testing with the purchase of Neurohacker Collective’s nootropic, Qualia Mind. Participants were asked to complete the testing before starting on Qualia Mind and again after five days of using Qualia Mind.
Pilot Study Using Cambridge Brain Sciences Quantitative Tests
The results for the 23 eligible subjects revealed meaningful improvement in core cognitive areas of reasoning, verbal ability and concentration. After 5 days of taking Qualia Mind, participants saw:
Preliminary data from cognitive testing of Qualia Mind customers
23 Participants (April-June 2018)
Verbal Ability & Cognition
Core Cognitive Area
|Outcome Measure||Verbal Resoning||Verbal Short-Term Memory||Concentrate / Avoid Distraction|
|Mean Score Increase 1 (%)||16.9%||13.3%||85.4%|
|Expected Learning Effect 2 (%)||2.2%||1.3%||4.9%|
|Outcome Description||Ability to quickly understand and make valid conclusions about verbal concepts||Ability to temporarily store information in a specific order in short-term||Ability to concentrate on relevant information despite distracting|
Reasoning & Memory
Core Cognitive Area
|Mean Score Increase 1 (%)||31.1%||37.2%||10.2%|
|Expected Learning Effect 2 (%)||5.4%||3.8%||-0.4%|
|Outcome Description||Ability to efficiently manipulate mental representations of objects||Ability to act with forethought and sequence behavior to reach specific goals||Ability to remember and recall specific events, paired with the context they occurred|
All participants were new Qualia Mind customers who purchased the product through the Neurohacker website between April 15, 2018 and May 25, 2018. Participants were asked to take the CBS battery of assessments before taking Qualia Mind for the first time and after 5 days from first dose. After taking the final assessment, participants were asked to take a short survey to record product usage data to ensure they were taking it according to usage instructions.
About Cambridge Brain Sciences
Cambridge Brain Sciences is a leading online brain health assessment platform. Their assessments of brain function and brain health have been taken millions of times and used in over 300 studies published in leading academic journals over the last 25 years. Cambridge Brain Sciences is headquartered in Toronto, Canada and has helped hundreds of thousands of people from 75+ countries gain greater insight into their brain health every day. Visit cambridgebrainsciences.com to learn more.
Note: For those of you familiar with Cambridge Brain Sciences testing, you’ll note that there’s a total of 12 different assessments offered. We had the participants of this study do all 12 assessments but have only published the results of 6 of the assessments. The other 6 didn’t have a large enough test population to have a high confidence margin in the results. We wanted to only put forward results on tests with p<0.05. As we have larger test audiences we’ll continue to publish more results